Ownership history in BB BIOTECH AG · 20 quarters on record
This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Agios Pharmaceuticals Inc. (AGIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2019 Q1 | ADDED | 2,978,134 | +100,000 | +3.5% | 5.05% | $200.8M | $67.44 |
| 2018 Q4 | ADDED | 2,878,134 | +680,203 | +30.9% | 4.25% | $132.7M | $46.11 |
| 2018 Q3 | UNCHANGED | 2,197,931 | — | 0% | 4.49% | $169.5M | $77.12 |
| 2018 Q2 | REDUCED | 2,197,931 | -337,322 | -13.3% | 5.35% | $185.1M | $84.23 |
| 2018 Q1 | REDUCED | 2,535,253 | -184,745 | -6.8% | 5.73% | $207.3M | $81.78 |
| 2017 Q4 | REDUCED | 2,719,998 | -30,000 | -1.1% | 4.38% | $155.5M | $57.17 |
| 2017 Q3 | REDUCED | 2,749,998 | -119,530 | -4.2% | 5.08% | $183.6M | $66.75 |
| 2017 Q2 | ADDED | 2,869,528 | +30,000 | +1.1% | 4.51% | $147.6M | $51.45 |
| 2017 Q1 | ADDED | 2,839,528 | +30,000 | +1.1% | 5.42% | $165.8M | $58.40 |
| 2016 Q4 | ADDED | 2,809,528 | +160,000 | +6.0% | 4.34% | $117.2M | $41.73 |
As of 2025 Q4 — sorted by position size